For citation:
Boyko A.N., Spirin N.N., Vlasov Y.V., Zakharova M.N. Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):166-171. (In Russ.) https://doi.org/10.14412/2074-2711-2019-4-166-171